Revelation Biosciences, Inc. (REVB)
3.50
-0.29
(-7.65%)
USD |
NASDAQ |
Oct 26, 16:00
3.50
0.00 (0.00%)
After-Hours: 20:00
Revelation Biosciences Market Cap : 1.954M for Oct. 26, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 2.116M |
| October 22, 2026 | 2.054M |
| October 21, 2026 | 2.010M |
| October 20, 2026 | 2.094M |
| October 19, 2026 | 1.834M |
| October 16, 2026 | 1.894M |
| October 15, 2026 | 2.979M |
| October 14, 2026 | 19.69M |
| October 13, 2026 | 19.98M |
| October 12, 2026 | 21.19M |
| October 09, 2026 | 20.79M |
| October 08, 2026 | 21.17M |
| October 07, 2026 | 22.66M |
| October 06, 2026 | 20.58M |
| October 05, 2026 | 21.26M |
| October 02, 2026 | 20.89M |
| October 01, 2026 | 21.91M |
| September 30, 2026 | 22.35M |
| September 29, 2026 | 22.27M |
| September 28, 2026 | 23.51M |
| September 25, 2026 | 23.81M |
| September 24, 2026 | 23.81M |
| September 23, 2026 | 25.56M |
| September 22, 2026 | 26.81M |
| September 21, 2026 | 26.71M |
| Date | Value |
|---|---|
| September 18, 2026 | 25.45M |
| September 17, 2026 | 25.99M |
| September 16, 2026 | 25.17M |
| September 15, 2026 | 24.91M |
| September 14, 2026 | 26.13M |
| September 11, 2026 | 27.15M |
| September 10, 2026 | 27.34M |
| September 09, 2026 | 27.63M |
| September 08, 2026 | 27.63M |
| September 04, 2026 | 27.63M |
| September 03, 2026 | 27.63M |
| September 02, 2026 | 27.36M |
| September 01, 2026 | 26.99M |
| August 31, 2026 | 27.36M |
| August 28, 2026 | 28.73M |
| August 27, 2026 | 28.18M |
| August 26, 2026 | 26.13M |
| August 25, 2026 | 27.36M |
| August 24, 2026 | 30.09M |
| August 21, 2026 | 29.82M |
| August 20, 2026 | 29.27M |
| August 19, 2026 | 30.37M |
| August 18, 2026 | 30.37M |
| August 17, 2026 | 31.46M |
| August 14, 2026 | 28.70M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Shuttle Pharmaceuticals Holdings, Inc. | 5.146M |
| ACADIA Pharmaceuticals, Inc. | 3.397B |
| Agenus, Inc. | 262.09M |
| Alnylam Pharmaceuticals, Inc. | 30.44B |
| Amgen, Inc. | 240.39B |
Market Cap Related Metrics
| Price to Book Value | 0.1941 |
| Price | 3.50 |
| Earnings Yield | -2.46K% |